1. Home
  2. IDYA vs MANU Comparison

IDYA vs MANU Comparison

Compare IDYA & MANU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$31.94

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Manchester United Ltd.

MANU

Manchester United Ltd.

HOLD

Current Price

$17.93

Market Cap

3.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
MANU
Founded
2015
1878
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
IDYA
MANU
Price
$31.94
$17.93
Analyst Decision
Strong Buy
Analyst Count
16
0
Target Price
$51.21
N/A
AVG Volume (30 Days)
757.3K
320.9K
Earning Date
05-19-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
61.90
N/A
EPS
N/A
N/A
Revenue
$218,710,000.00
N/A
Revenue This Year
N/A
$0.01
Revenue Next Year
$97.58
$15.68
P/E Ratio
N/A
N/A
Revenue Growth
3024.43
N/A
52 Week Low
$13.45
$12.05
52 Week High
$39.28
$18.94

Technical Indicators

Market Signals
Indicator
IDYA
MANU
Relative Strength Index (RSI) 45.48 58.30
Support Level $29.15 $16.86
Resistance Level $33.64 $18.10
Average True Range (ATR) 1.47 0.58
MACD 0.10 -0.03
Stochastic Oscillator 59.47 80.34

Price Performance

Historical Comparison
IDYA
MANU

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About MANU Manchester United Ltd.

Manchester United PLC operates as a professional football club with related activities, generating revenue prominently through commercial, broadcasting, and matchday segments. The commercial segment monetizes the various brands via sponsorships, retail, merchandising, apparel, and product licensing. Broadcasting revenue comes from television rights linked to football leagues and competitions, alongside content delivered through its dedicated TV channel all over the globe. Matchday income includes ticket sales, hospitality, merchandise, and services at its stadium. Manchester United is based in England. The company's operations and fan base extends to many countries, supporting a diversified revenue model based on brand engagement and football-related content.

Share on Social Networks: